Ep188: Art Krieg on Innate Immune System Activators for Cancer
The Long Run with Luke Timmerman
00:00
Understanding immune suppression in tumors
Art explains how tumor-associated suppressive myeloid cells lacked TLR9, limiting CpG efficacy in many patients.
Play episode from 38:39
Transcript
